Skip to main content
Top
Published in: Diabetes Therapy 5/2017

Open Access 01-10-2017 | Original Research

Healthcare Resource Utilization and Costs Associated with Ketosis Events in Pediatric and Adult Patients with Type 1 Diabetes Mellitus in the UK

Authors: Nandu Thalange, Natalie Valerie Jane Aldhouse, Helen Kitchen, Daniel Howard, Deniz Tutkunkardas, Jonas Håkan-Bloch

Published in: Diabetes Therapy | Issue 5/2017

Login to get access

Abstract

Introduction

Ketosis is a metabolic state associated with insulin deficiency. Untreated, it develops into diabetic ketoacidosis, a significant contributor to mortality and morbidity in people with type 1 diabetes mellitus (T1DM). Little is understood about how patients utilize healthcare resources during ketosis events. This study aimed to identify and quantify healthcare resource utilization and provide estimates of associated costs of ketosis events in T1DM, treated unaided or with healthcare professional (HCP) assistance in the UK.

Methods

Qualitative interviews with adult patients, pediatric carers, and HCPs identified resources used by patients/carers during ketosis events. An online quantitative survey was then used to quantify patients/carers resource use during their/their child’s most recent ketosis event, and HCPs estimated patient resource uptake to corroborate the findings. Associated costs estimated from UK data sources were applied to the survey results to calculate the cost of ketosis events in adults and children.

Results

Quantitative survey responses from 93 adults, 76 carers, and 52 HCPs were analyzed. Patients and carers monitored ketosis during and following the event with ketone strips and additional glucose strips, and administered treatment comprising insulin and pump set changes where appropriate. Additionally, patients/carers accessed phone services and many received follow-up medical appointments. In total, 70% (n = 65) of adult and 66% (n = 50) of pediatric ketosis events were managed at home, for which resource use costs per event were £23.87 and £38.00 respectively. Remaining events were treated in NHS facilities costing £217.57 per adult and £352.92 per child. Weighted averages identified that ketosis events cost £81.98 per adult and £142.97 per child. Indirect costs from work productivity loss increase these figures to £225.11 per adult and £256.88 per child.

Conclusions

Healthcare resource use for ketosis events is high in adults and children with T1DM and imposes an underappreciated economic burden for the NHS.

Funding

Novo Nordisk A/S.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parekh W, Ashley D, Chubb B, Gillies H, Evans M. Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool. Diabet Med. 2015;32(9):1156–66CrossRefPubMedPubMedCentral Parekh W, Ashley D, Chubb B, Gillies H, Evans M. Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool. Diabet Med. 2015;32(9):1156–66CrossRefPubMedPubMedCentral
2.
go back to reference Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999;15(6):412–26.CrossRefPubMed Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999;15(6):412–26.CrossRefPubMed
4.
go back to reference Wright J, Ruck K, Rabbitts R, et al. Diabetic ketoacidosis (DKA) in Birmingham, UK, 2000–2009: an evaluation of risk factors for recurrence and mortality. Br J Diabetes Vasc Dis. 2009;9(6):278–82.CrossRef Wright J, Ruck K, Rabbitts R, et al. Diabetic ketoacidosis (DKA) in Birmingham, UK, 2000–2009: an evaluation of risk factors for recurrence and mortality. Br J Diabetes Vasc Dis. 2009;9(6):278–82.CrossRef
15.
go back to reference Tukey J. Exploratory data analysis. Reading: Addison-Wesley; 1977. Tukey J. Exploratory data analysis. Reading: Addison-Wesley; 1977.
16.
go back to reference Mathieu C, Zinman B, Hemmingsson JU, al. Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes: the ADJUNCT ONE treat-to-target randomized trial. Diabetes Care. 2016;39(10):1702–10.CrossRefPubMed Mathieu C, Zinman B, Hemmingsson JU, al. Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes: the ADJUNCT ONE treat-to-target randomized trial. Diabetes Care. 2016;39(10):1702–10.CrossRefPubMed
19.
go back to reference Brod M, Christensen T, Thomsen TL, Bushnell DM. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health. 2011;14(5):665–71.CrossRefPubMed Brod M, Christensen T, Thomsen TL, Bushnell DM. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health. 2011;14(5):665–71.CrossRefPubMed
20.
go back to reference Agarwal S, Garvey KC, Raymond JK, Schutta MH. Perspectives on care for young adults with type 1 diabetes transitioning from pediatric to adult health systems: a national survey of pediatric endocrinologists. Pediatr Diabetes. 2016;. doi:10.1111/pedi.12436. Agarwal S, Garvey KC, Raymond JK, Schutta MH. Perspectives on care for young adults with type 1 diabetes transitioning from pediatric to adult health systems: a national survey of pediatric endocrinologists. Pediatr Diabetes. 2016;. doi:10.​1111/​pedi.​12436.
22.
go back to reference O’Cathain A, Knowles E, Nicholl J. Testing survey methodology to measure patients’ experiences and views of the emergency and urgent care system: telephone versus postal survey. BMC Med Res Methodol. 2010;10:52. O’Cathain A, Knowles E, Nicholl J. Testing survey methodology to measure patients’ experiences and views of the emergency and urgent care system: telephone versus postal survey. BMC Med Res Methodol. 2010;10:52.
23.
go back to reference Thalange N, Deeb L, Iotova V, et al. Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes. Paediatr Diabetes. 2015;16(3):164–76.CrossRef Thalange N, Deeb L, Iotova V, et al. Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes. Paediatr Diabetes. 2015;16(3):164–76.CrossRef
24.
go back to reference Elliott J, Jacques R, Kruger J, et al. Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with type 1 diabetes. Diabet Med. 2014;31(7):847–53.CrossRefPubMedPubMedCentral Elliott J, Jacques R, Kruger J, et al. Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with type 1 diabetes. Diabet Med. 2014;31(7):847–53.CrossRefPubMedPubMedCentral
25.
go back to reference Hoffman WH, O’Neill P, Khoury C, Bernstein SS. Service and education for the insulin-dependent child. Diabetes Care. 1978;1(5):285–8.CrossRefPubMed Hoffman WH, O’Neill P, Khoury C, Bernstein SS. Service and education for the insulin-dependent child. Diabetes Care. 1978;1(5):285–8.CrossRefPubMed
Metadata
Title
Healthcare Resource Utilization and Costs Associated with Ketosis Events in Pediatric and Adult Patients with Type 1 Diabetes Mellitus in the UK
Authors
Nandu Thalange
Natalie Valerie Jane Aldhouse
Helen Kitchen
Daniel Howard
Deniz Tutkunkardas
Jonas Håkan-Bloch
Publication date
01-10-2017
Publisher
Springer Healthcare
Published in
Diabetes Therapy / Issue 5/2017
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-017-0305-0

Other articles of this Issue 5/2017

Diabetes Therapy 5/2017 Go to the issue